Biomechanics Based Prediction of Preterm Delivery
- Conditions
- Preterm Delivery
- Interventions
- Device: Pregnolia System
- Registration Number
- NCT02037334
- Lead Sponsor
- David Scheiner
- Brief Summary
Quantitative information on the biomechanical properties of the ecto-cervix in mid-pregnancy will be compared between women with term vs. preterm delivery. We aim to demonstrate that biomechanical data (ASP and CCI) might complement morphological data (CL) to improve prediction of preterm delivery. It is expected that women with preterm delivery will show stronger weakening of cervical tissue. Aspiration (ASP) and cervical CCI (cervical consistency index) measurements are performed at mid-pregnancy: detection at this time point is useful for therapy and biomechanical modifications are already significant so to enable differentiation by biomechanical measurements (ASP and CCI).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1002
- All pregnant women presenting at their mid pregnancy consultation (18+0 - 22+0 weeks of pregnancy) are eligible
- Signed informed consent after being informed is a prerequisite for enrollment.
- Communication problems
- Missing consent
- Age<18
- Active bleeding / Premature Rupture of Membranes (PROM)
- Active genital infection
- Known carrier of HIV or Hepatitis B or C
- Placenta praevia
- Müllerian anomalies
- known or suspected non-compliance, drug or alcohol abuse
- cerclage
- use of pessary
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pregnancy Pregnolia System -
- Primary Outcome Measures
Name Time Method Difference in cervical stiffness in women with/without preterm delivery Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum The biomechanical measurements and morphological data obtained at mid-pregnancy are compared between women with/without preterm delivery and are expected to significantly differ. The diagnostic power for preterm delivery of aspiration, CCI and the other factors will be determined.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (13)
Praxis Zollikon
🇨🇭Zollikon, Switzerland
Kantonsspital Aarau, Frauenklinik
🇨🇭Aarau, Switzerland
Hôpitaux universitaires de Genève (HUG)
🇨🇭Genève, Switzerland
University Hospital of Leuven
🇧🇪Leuven, Belgium
Universitätsspital Basel, Frauenklinik
🇨🇭Basel, Switzerland
Kantonsspital Baden, Frauenklinik
🇨🇭Baden, Switzerland
Kantonsspital Frauenfeld, Frauenklinik
🇨🇭Frauenfeld, Switzerland
Kantonsspital Luzern, Frauenklinik
🇨🇭Luzern, Switzerland
Kantonsspital St. Gallen, Klinik für Gynäkologie und Geburtshilfe
🇨🇭St. Gallen, Switzerland
Kantonsspital Winterthur
🇨🇭Winterthur, Switzerland
University Hospital of Zurich, Dept. OB/Gyn
🇨🇭Zurich, Switzerland
Stadtspital Triemli, Frauenklinik
🇨🇭Zurich, Switzerland
Kantonsspital Münsterlingen
🇨🇭Münsterlingen, Switzerland